Epidemiological characteristics and risk factors analysis of liver cancer in Guangxi
DOI:
https://doi.org/10.53797/fphj.v3i2.9.2024Keywords:
Liver cancer, Epidemiology, Risk factors, GuangxiAbstract
This study aims to explore the epidemiological characteristics and related risk factors of primary liver cancer in Guangxi. The research collected medical records of 610 patients diagnosed with liver cancer at the Affiliated Hospital of Youjiang Medical University for Nationalities from 2014 to 2023. Factors such as gender, age, ethnicity, urban-rural distribution, medical history, smoking history, alcohol consumption history, treatment methods, and complications were analyzed using a chi-square test. The results showed that liver cancer patients were primarily middle-aged males, with a higher proportion of Zhuang ethnic group and rural patients. There was a significant correlation between a history of liver disease and the onset of the disease. Although smoking and alcohol consumption did not show statistical significance, their potential risks still require attention. This study provides a scientific basis for early screening and prevention strategies for liver cancer and emphasizes the importance of health interventions targeting high-risk populations.
References
References
Forner, A., & Reig, M. (2018). carcinoma Bruix JHepatocellular. Lancet, 391(10127), 1301-14.
Wang, H., Shi, F., Zheng, S., Zhao, M., Pan, Z., Xiong, L., & Zheng, L. (2022). Feasibility of hepatocellular carcinoma treatment based on the tumor microenvironment. Frontiers in Oncology, 12, 896662.
Miller, D. L. (1995). Perioperative care of the elderly patient: special considerations. Cleveland Clinic Journal of Medicine, 62(6), 383-390.
Qin, Y., Tang, C., Li, J., & Gong, J. (2024). Liver cancer in China: the analysis of mortality and burden of disease trends from 2008 to 2021. BMC cancer, 24(1), 594.
Hartke, J., Johnson, M., & Ghabril, M. (2017, March). The diagnosis and treatment of hepatocellular carcinoma. In Seminars in diagnostic pathology (Vol. 34, No. 2, pp. 153-159). WB Saunders.
Singal, A. G., Kanwal, F., & Llovet, J. M. (2023). Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nature reviews Clinical oncology, 20(12), 864-884.
Meng, L., Yang, R., Su, N., Shen, T., Qu, X., & Sun, H. (2023). Spatial epidemiological analysis of the burden of liver cancer in China. Translational Cancer Research, 13(1), 363.
Zhang, C. Y., Huang, T. R., Yu, J. H., Zhang, Z. Q., Li, J., Deng, W., ... & He, Z. (2010). Epidemiological analysis of primary liver cancer in the early 21st century in Guangxi province of China. Chinese journal of cancer, 29(5), 545-550.
Zhang, Z. Q. (1989). A cohort study on the relation of primary liver cancer and HBsAg positivity in Guangxi Province. Zhonghua yu Fang yi xue za zhi [Chinese Journal of Preventive Medicine], 23(3), 141-142.
Alderwick, H., Hutchings, A., Briggs, A., & Mays, N. (2021). The impacts of collaboration between local health care and non-health care organizations and factors shaping how they work: a systematic review of reviews. BMC Public Health, 21, 1-16.
Zheng, R., Qu, C., Zhang, S., Zeng, H., Sun, K., Gu, X., ... & He, J. (2018). Liver cancer incidence and mortality in China: temporal trends and projections to 2030. Chinese Journal of Cancer Research, 30(6), 571.
Grewal, P., & Viswanathen, V. A. (2012). Liver cancer and alcohol. Clinics in liver disease, 16(4), 839-850.
Heckley, G. A., Jarl, J., Asamoah, B. O., & G-Gerdtham, U. (2011). How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature. BMC cancer, 11, 1-10.
Im, P. K., Wright, N., Yang, L., Chan, K. H., Chen, Y., Guo, Y., ... & Millwood, I. Y. (2023). Alcohol consumption and risks of more than 200 diseases in Chinese men. Nature medicine, 29(6), 1476-1486.
Eidam, A., Roth, A., Lacroix, A., Goisser, S., Seidling, H. M., Haefeli, W. E., & Bauer, J. M. (2020). Methods to assess patient preferences in old age pharmacotherapy–a systematic review. Patient preference and adherence, 467-497.
Song, P., Feng, X., Zhang, K., Song, T., Ma, K., Kokudo, N., ... & Tang, W. (2013). Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China. Bioscience trends, 7(1), 1-6.
Forner, A., Hessheimer, A. J., Real, M. I., & Bruix, J. (2006). Treatment of hepatocellular carcinoma. Critical reviews in oncology/hematology, 60(2), 89-98.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Wei Peiyan, Sher Zaman Safi
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
